RDY - Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript
2024-05-07 14:42:05 ET
Dr. Reddy's Laboratories Limited (RDY)
Q4 2024 Earnings Conference Call
May 07, 2024 10:00 AM ET
Company Participants
Richa Periwal - Head of Investor Relations
GV Prasad - Co-Chairman and Managing Director
Parag Agarwal - Chief Financial Officer
Erez Israeli - Chief Executive Officer
Conference Call Participants
Neha Manpuria - Bank of America Merrill Lynch
Kunal Dhamesha - Macquarie Capital Securities
Saion Mukherjee - Nomura Securities
Tarang Agrawal - Old Bridge Capital
Tushar Manudhane - Motilal Oswal Financial Services
Nitesh Dutt - Burman Capital
Ankush Mahajan - Axis Securities
Surya Patra - PhillipCapital India Private Limited.
Madhav Marda - FIL Research
Bino Pathiparampil - Elara Capital
Presentation
Operator
Ladies and gentlemen, good day, and welcome to the Q4 and Full-Year FY2024 Earnings Conference Call of Dr. Reddy's Laboratories Limited. As a reminder, all participant lines will be in the listen-only mode. There will be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions] Please note that this conference is being recorded.
I now hand the conference over to Ms. Richa Periwal. Thank you, and over to you, Ma'am.
Richa Periwal
Thank you. A very good morning and good evening to all of you and thank you for joining us today for the Dr. Reddy's earnings conference call for the quarter and full-year ended, March 31, 2024. Earlier during the day, we have released our results and the same was also posted on our website. This call is being recorded and the playback and transcript shall be made available on our website soon.
All the discussions and analysis of this call will be based on the IFRS consolidated financial statements. The discussion today contains certain non-GAAP financial measures. For a reconciliation of GAAP to non-GAAP measures, please refer to our press release.
To discuss the business performance and outlook, we have the leadership of Dr. Reddy's comprising Mr. GV Prasad, our Co-Chairman and Managing Director; Mr. Erez Israeli, our CEO; Mr. Parag Agarwal, our CFO and the entire Investor Relations team.
Please note that today's call is a copyrighted material of Dr. Reddy's, and cannot be re-broadcasted or attributed in press or media outlets without the Company's expressed written consent. Before I proceed with the call, I would like to remind everyone that the safe harbor contained in today's press release also pertains to this conference call.
Now, I hand over the call to Mr. GV Prasad. Over to you, sir.
GV Prasad
Thank you, Richa. Good morning and good evening to all the participants here. Welcome to the annual earnings call of Dr. Reddy's. I am delighted to be here today along with the members of the management team and the IR team. As many of you know, I joined the earnings call each year at the end of the financial year....
Dr. Reddy's Laboratories Limited (RDY) Q4 2024 Earnings Call Transcript